Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (91-100 of 217) with videos related to

Pageof 22
Sort By:
American Journal of Cancer Research|September 10, 2019
Wild-type <i>TP53</i> defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCsChen Zhang, Emmanuel Martinez-Ledesma, Feng Gao, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuro-Oncology|April 27, 2022
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastomaJie Ding, Xiaolong Li, Sabbir Khan, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomasHong Jiang, Candelaria Gomez-Manzano, Ramon Alemany, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Neuro-Oncology|August 19, 2008
VEGF Trap induces antiglioma effect at different stages of diseaseCandelaria Gomez-Manzano, Jocelyn Holash, Juan Fueyo, et al.
Neuro-Oncology Advances|December 22, 2023
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastomaSabbir Khan, Emmanuel Martinez-Ledesma, Jianwen Dong, et al.
Cancer Research|August 18, 2004
Polymorphisms of DNA repair genes and risk of gliomaLi-E Wang, Melissa L Bondy, Hongbing Shen, et al.
Molecular Cancer Therapeutics|March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.
Pageof 22

Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
American Journal of Cancer Research|September 10, 2019
Wild-type <i>TP53</i> defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCsChen Zhang, Emmanuel Martinez-Ledesma, Feng Gao, et al.
Neuro-Oncology Advances|March 19, 2021
The promise of DNA damage response inhibitors for the treatment of glioblastomaNazanin K Majd, Timothy A Yap, Dimpy Koul, et al.
Neuro-Oncology|April 27, 2022
EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastomaJie Ding, Xiaolong Li, Sabbir Khan, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomasHong Jiang, Candelaria Gomez-Manzano, Ramon Alemany, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710Howard Colman, Brian A Berkey, Moshe H Maor, et al.
Neuro-Oncology|October 3, 2002
Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategiesFrederick F Lang, Mark R Gilbert, Vinay K Puduvalli, et al.
Neuro-Oncology|August 19, 2008
VEGF Trap induces antiglioma effect at different stages of diseaseCandelaria Gomez-Manzano, Jocelyn Holash, Juan Fueyo, et al.
Neuro-Oncology Advances|December 22, 2023
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastomaSabbir Khan, Emmanuel Martinez-Ledesma, Jianwen Dong, et al.
Cancer Research|August 18, 2004
Polymorphisms of DNA repair genes and risk of gliomaLi-E Wang, Melissa L Bondy, Hongbing Shen, et al.
Molecular Cancer Therapeutics|March 21, 2006
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastomaDimpy Koul, Ruijun Shen, Sherry Bergh, et al.
Pageof 22